Please login to the form below

Not currently logged in
Email:
Password:

JMC Partners honoured at health comms awards

Wins small consultancy of the year at the Communiqué Awards 2013

Communique 2013 winner small consultancy

JMC Partners was last week recognised for its work in healthcare communications, picking up Small Consultancy of the Year at the Communiqué Awards 2013.

The judges said JMC was an “amazing agency” that had a “nurturing approach towards its people” and the honour comes a year after the company celebrated its tenth anniversary, a milestone that prompted the agency to take a more active marketing stance.

This renewed focus helped London based JMC Partners increase turnover by 65 per cent as existing accounts were strengthened and new clients were brought on board.

Nevertheless, JMC Partner had to beat off tough competition in the category with the judges awarding infill Kommunikation GmbH from Königswinter, Germany with a Highly Commended prize.

“The spirit of Communiqué was truly felt in this category, with inspiring and engaging entries showing that it's never too late to change,” said one judge.

The Communiqué programme, which took place at London's Grosvenor House Hotel, Park Lane, is run by PMLiVE publishers PMGroup and is specifically designed to recognise and commend excellence and best practice in local, European and international healthcare communications.

• See the full results of the Communiqué Awards 2013
• See all the photos from the Communiqué Awards 2013

8th July 2013

From: Marketing, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...